Pharma News: Vivus, Inc. (VVUS)'s New CEO, Arena Pharmaceuticals, Inc. (ARNA) & Amgen, Inc. (AMGN)'s Positive Earnings
VIVUS, Inc. (NASDAQ:VVUS), which sells the obesity drug Qsymia, has appointed Anthony Zook to serve as its CEO.
Vivus Inc (VVUS)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): How You Should Play These Weight-Loss Drug Companies
The two weight-loss drug approvals in 2012 were the first in more than a decade. The excitement surrounding Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’ Belviq and VIVUS, Inc.
VIVUS, Inc. (VVUS), AstraZeneca plc (ADR) (AZN): Great Job, Now You're Fired
"As a founding CEO, over the past 22 years, Leland has secured four drug approvals, an unheard-of achievement for a small pharmaceutical company. He has taken VIVUS, Inc.
Warren Buffett News: New Acquisition, DaVita HealthCare Partners Inc (DVA) Rumors & Berkshire Hathaway Inc. (BRK.A)
When Dr. Sam Colin was an intern at the Yale School of Medicine, he often gave up the chance to catch a few minutes of sleep between shifts to read the latest investment insights from Warren Buffett.
What Should You Expect From Arena Pharmaceuticals, Inc. (ARNA) and VIVUS, Inc. (VVUS)?
For a long time, VIVUS, Inc. (NASDAQ:VVUS) was operating as the only player in the anti-obesity market. However, the entry by Arena Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS), Merck & Co., Inc. (MRK): What's Your Biggest Fear? The Answer Might Scare You!
With all of the factors we have to worry about in our everyday lives, it is somewhat a wonder that we're not only able to survive, but thrive, as a society.
Eli Lilly & Co. (LLY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The 3 Most Commonly Diagnosed Mental Disorders
The medical community certainly spends a lot of time and money researching treatments for cardiovascular disease and cancer.
Drug Deal Can Only Help VIVUS, Inc. (VVUS) So Much
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Arena Pharmaceuticals, Inc. (ARNA): 1 Biotech You Might Want to Explore Right Now!
After more than a year, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’ weight-loss drug Belviq has finally launched.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
